Dexcom Balance Sheet
DXCM / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
Dexcom had $6.3B in total assets and $2.7B in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 26.4%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $917.7M | $606.1M | $566.3M | $1.1B | $1.1B | $817.6M | $446.2M | $1.1B | $94.5M | $71.8M | $43.2M | $71.8M | $43.2M | $8.1M | $2.6M |
| Accounts Receivable | $1.2B | $1.0B | $973.9M | $713.3M | $514.3M | $428.5M | $286.3M | $226.7M | $134.3M | $101.7M | $74.1M | $42.4M | $26.1M | $19.5M | $12.5M |
| Inventory | $629.1M | $542.6M | $559.6M | $306.7M | $357.3M | $234.7M | $119.8M | $70.7M | $45.2M | $45.4M | $35.2M | $16.0M | $9.0M | $7.4M | $8.2M |
| Current Assets | $4.0B | $4.3B | $4.4B | $3.7B | $3.7B | $3.4B | $2.0B | $1.7B | $744.7M | $280.0M | $231.3M | $145.9M | $93.1M | $77.6M | $104.5M |
| PP&E (Net) | $1.6B | $1.3B | $1.1B | $1.1B | $801.8M | $515.3M | $321.3M | $183.1M | $145.6M | $109.4M | $54.7M | $31.2M | $20.7M | $18.9M | $15.0M |
| Goodwill | $24.2M | $22.8M | $25.2M | $25.7M | $26.5M | $19.3M | $18.6M | $18.7M | $12.1M | $11.3M | $3.7M | $3.2M | $3.2M | $3.2M | $0 |
| Total Assets | $6.3B | $6.5B | $6.3B | $5.4B | $4.9B | $4.3B | $2.4B | $1.9B | $904.1M | $402.8M | $292.0M | $184.6M | $122.5M | $106.0M | $120.5M |
| Current Liabilities | $2.1B | $2.9B | $1.6B | $1.8B | $720.8M | $614.1M | $360.2M | $222.4M | $138.9M | $102.4M | $66.9M | $40.6M | $32.1M | $19.5M | $14.7M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | $4.6M | $6.8M | $7.0M | - |
| Shareholders' Equity | $2.7B | $2.1B | $2.1B | $1.6B | $2.0B | $1.6B | $882.6M | $663.3M | $221.2M | $140.2M | $84.1M | $140.2M | $84.1M | $77.0M | $104.5M |